The AACR Call to Action
Cancer Progress Report 2014: Contents
In this section you will learn:
We are now at a crossroads in our country’s long struggle to prevent and cure cancer; we must choose between two paths, but there is only one viable path forward to continue transforming lives.
On the viable path we seize the momentum at this exciting time in biomedical research by committing to budget increases for the NIH and NCI so that the remarkable progress of the past can continue at a rapid pace.
To take the alternative path is simply unacceptable. This particularly dangerous path leads us to a place where federal funding for biomedical research remains stagnant or, even worse, declines, seriously jeopardizing the rate at which we are able to make progress. On this path, breakthroughs and discoveries will be slowed, meaning that delivery of the cures that patients and their loved ones desperately need is delayed. Early-career researchers may be forced to leave science for other fields, further jeopardizing continued future progress.
The AACR respectfully urges Congress to do the right thing for cancer patients and our nation and choose the only viable path forward, which is
to prioritize the growth of the NIH and NCI budgets at a predictable, robust pace by providing annual budget increases at least comparable to the biomedical inflation rate.
Rededicating our country to the promise of biomedical research requires strong leadership from the administration and Congress. It also requires a commitment from all Americans to support federal funding for biomedical research and to communicate this view to policymakers.
As a country we must set priorities and make difficult choices at this fiscally challenging time in our history. Our federal government can do no better than invest robustly in the NIH and the NCI to ensure that the path we follow will lead us to a brighter future for the millions of people whose lives have been touched by cancer.
Progress Report 2014 Contents